LABO PLUS
ActiveSummary
The computed 12-month bankruptcy probability of LABO PLUS is 2.2% (moderate). The 2024 annual accounts show equity of €136,537 and a net result of -€5,646. Equity is growing by about 6.5% per year across the filed financial years. Its solvency ranks better than 41% of 15,442 sector peers (NACE 46, financial year 2024). The company has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
2 directors, last change in 2026
TAGA Mélisa
CurrentDirector · since 01-11-2025
Selin Erdil
CurrentAdministratrice supplémentaire · since 10-08-2026
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
4 of this company's 6 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
3 people since 2025, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| TAGA Mélisa |
|
| Selin Erdil |
|
| KANLIBAS Deniz |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
Stated in the act
act of 15-12-2025 ↗
- AKDAS Susana 50 shares
- HAMARAT Hüsnü Deniz 17 shares
- AMATO Cetin 17 shares
- REDJEL Abdelmoumen 16 shares
Share transfer
act of 15-12-2025 ↗
- GIER Denis to AKDAS Susana 50 shares
- KANLIBAS Hakan to REDJEL Abdelmoumen 16 shares
- KANLIBAS Hakan to HAMARAT Hüsnü Deniz 17 shares
- KANLIBAS Hakan to AMATO Cetin 17 shares
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.